Health Catalyst, Inc. — Director's Dealing 2019

Jul 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2019-07-29

Reporting Person: Cozzens Todd C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-29	Common Stock	C	43967	—	Acquired	134331	Direct
2019-07-29	Common Stock	C	6344	—	Acquired	140675	Indirect
2019-07-29	Common Stock	C	943484	—	Acquired	1084159	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-29	Series C Preferred Stock	$	C	43967	Disposed		Common Stock (43967.0)	Direct
2019-07-29	Series D Preferred Stock	$	C	6344	Disposed		Common Stock (6344.0)	Direct
2019-07-29	Series E Preferred Stock	$	C	943484	Disposed		Common Stock (943484.0)	Direct

Footnotes

F1: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F2: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F3: The shares are held by Matoaka, LLC and the Reporting Person holds the voting and dispositive power over the shares.

F4: Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F5: The shares are held by Leerink Transformation Fund I, L.P. ("Leerink") and the Reporting Person is a co-founder and Managing Partner of Leerink and holds voting and dispositive power over the shares.